Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2006, Vol. 107, No. 2, pp. 584-590.
Prepublished online as a Blood First Edition Paper on September 27, 2005; DOI 10.1182/blood-2005-07-3033.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-07-3033v1
107/2/584    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licht, A. H
Right arrow Articles by Breier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licht, A. H
Right arrow Articles by Breier, G.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 28, 2005
Accepted September 12, 2005

Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development

Alexander H Licht, Felix Muller-Holtkamp, Ingo Flamme, and Georg Breier*

Department of Pathology, Faculty of Medicine, University of Technology, Dresden, Germany
Department of Molecular Cell Biology, Max Planck Institute for Physiological and Clinical Research, Bad Nauheim, Germany
Bayer Health Care, Wuppertal, Germany

* Corresponding author; email: georg.breier{at}uniklinikum-dresden.de.

Hypoxia-inducible factors (HIFs) are transcriptional regulators that mediate the cellular response to low oxygen levels. By stimulating the expression of angiogenic growth factors such as vascular endothelial growth factor (VEGF), they trigger the neovascularization of tissues under physiological and pathological conditions. Here, we have investigated the endothelial cell autonomous HIF function in blood vessel growth and development, by expressing a dominant negative HIF mutant (HIFdn) that inhibits the transcriptional responses mediated by both HIF-1 and HIF-2, specifically in endothelial cells of transgenic mice. HIFdn transgenic embryos were growth retarded and died around E11.5. Primitive vascular networks were established, but vascular remodeling in the yolk sac and in the embryo proper was defective, and vascular sprouts failed to invade the neuroepithelium. In addition, heart-looping was incomplete, and the ventricles of the heart were thin-walled and lacked trabeculation. Similar cardiovascular defects have been observed in Tie-2 deficient mouse embryos. Consistently, HIFdn transgenic embryos expressed reduced levels of the endothelial angiopoietin receptor, Tie-2, whereas other endothelial markers, such as Pecam-1, Tie-1 and VE-cadherin were not affected. These results show that HIFs in endothelial cells are essential for embryonic heart and blood vessel development, and control angiogenesis and vascular remodeling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

EC does it with HIF
Gregg L. Semenza
Blood 2006 107: 419-420. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
N. Skuli, L. Liu, A. Runge, T. Wang, L. Yuan, S. Patel, L. Iruela-Arispe, M. C. Simon, and B. Keith
Endothelial deletion of hypoxia-inducible factor-2{alpha} (HIF-2{alpha}) alters vascular function and tumor angiogenesis
Blood, July 9, 2009; 114(2): 469 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. V. Liu, M. E. Hubbi, F. Pan, K. R. McDonald, M. Mansharamani, R. N. Cole, J. O. Liu, and G. L. Semenza
Calcineurin Promotes Hypoxia-inducible Factor 1{alpha} Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
J. Biol. Chem., December 21, 2007; 282(51): 37064 - 37073.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. L. Semenza
Regulation of tissue perfusion in mammals by hypoxia-inducible factor 1
Exp Physiol, November 1, 2007; 92(6): 988 - 991.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. G. Nacak, A. Alajati, K. Leptien, C. Fulda, H. Weber, T. Miki, F. S. Czepluch, J. Waltenberger, T. Wieland, H. G. Augustin, et al.
The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis
Circ. Res., April 27, 2007; 100(8): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. Kojima, T. Tanaka, R. Inagi, H. Kato, T. Yamashita, A. Sakiyama, O. Ohneda, N. Takeda, M. Sata, T. Miyata, et al.
Protective Role of Hypoxia-Inducible Factor-2{alpha} against Ischemic Damage and Oxidative Stress in the Kidney
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1218 - 1226.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. A. Carroll, H. L. Kenerson, R. S. Yeung, and M. Lagunoff
Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Activates Hypoxia-Induced Factors
J. Virol., November 1, 2006; 80(21): 10802 - 10812.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020